Showing results (1791-1800 of 2,121) with videos related to

Sort By:
Pageof 213
BMJ Open|February 17, 2021
Australia IBD Microbiome (AIM) Study: protocol for a multicentre longitudinal prospective cohort studyAstrid-Jane Williams, Ramesh Paramsothy, Nan Wu, et al.
Infection and Immunity|October 17, 2018
Gene Expression Differences in Host Response to Schistosoma haematobium InfectionKathryn M Dupnik, Mary Juliet Reust, Kaitlin M Vick, et al.
Science Advances|November 27, 2018
HIV-1 vaccine design through minimizing envelope metastabilityLinling He, Sonu Kumar, Joel D Allen, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 28, 2014
Proteins associated with pancreatic cancer survival in patients with resectable pancreatic ductal adenocarcinomaRu Chen, David W Dawson, Sheng Pan, et al.
Plos Pathogens|December 29, 2025
A wide diversity of viruses detected in African mammals involved in the wild meat supply chainMare Geraerts, Sophie Gombeer, Casimir Nebesse, et al.
Blood Advances|April 9, 2024
Immunoglobulin replacement vs prophylactic antibiotics for hypogammaglobulinemia secondary to hematological malignancyZoe K McQuilten, Robert Weinkove, Le Thi Phuong Thao, et al.
Mucosal Immunology|January 19, 2020
Intestinal epithelial NAIP/NLRC4 restricts systemic dissemination of the adapted pathogen Salmonella Typhimurium due to site-specific bacterial PAMP expressionAnnika Hausmann, Desirée Böck, Petra Geiser, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Native-like soluble E1E2 glycoprotein heterodimers on self-assembling protein nanoparticles for hepatitis C virus vaccine designLinling He, Yi-Zong Lee, Yi-Nan Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2013
A 26-gene hypoxia signature predicts benefit from hypoxia-modifying therapy in laryngeal cancer but not bladder cancerAmanda Eustace, Navin Mani, Paul N Span, et al.
Biotechnology and Bioengineering|November 19, 2017
cGMP production and analysis of BG505 SOSIP.664, an extensively glycosylated, trimeric HIV-1 envelope glycoprotein vaccine candidateAntu K Dey, Albert Cupo, Gabriel Ozorowski, et al.
Pageof 213